Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Inclusion Criteria: * Patients with transfusional iron overload who have successfully completed the one year chelation treatment in the deferasirox trial or the food-effect sub-study and who were considered by the investigator eligible to continue chelation therapy with deferasirox Exclusion Criteria: * Pregnant or breast feeding patients * Patients being considered by the investigator potentially unreliable and/or a history of non-compliance